Business CBD Health & Medicine News

Companies Scramble for CBD Patents, Igniting Fear of Corporate Cannabis

Something of a corporate scramble is underway to secure patents for the various curative properties of CBD, and the associated products and procedures. Pharmaceutical firms anticipate a windfall, but some activists raise concerns about the creeping privatization of cannabinoids that should belong to the genetic and intellectual commons of the human race.

SHARE
RELATED POSTS
Curaleaf Announces Closing of C$520 Million Offering and Begins Trading on the CSE Under Ticker Symbol “CURA”
Angelenos Are Getting Stoned At Higher Rates
Ancillary cannabis companies hit by declining economies pivot to emerging MJ markets

Leave Your Reply

*